BioGend Therapeutics Co., Ltd. (TPEX:6733)
25.95
+0.20 (0.78%)
May 29, 2026, 1:30 PM CST
-17.49% (1Y)
| Market Cap | 3.23B -6.7% |
| Revenue (ttm) | 229.81M +28.0% |
| Net Income | -67.11M |
| EPS | -0.55 |
| Shares Out | 124.36M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 188,255 |
| Open | 26.35 |
| Previous Close | 25.75 |
| Day's Range | 25.75 - 26.35 |
| 52-Week Range | 25.55 - 49.15 |
| Beta | 0.15 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 7, 2026 |